May 27, 2024 – Talk Bio

Actionable Insights Powered by AI

Ozempic Reduces Mortality Risk by 20% in Diabetes Patients with Chronic Kidney Disease

11 months ago11 months ago talkbio0Tagged Cardiovascular system, Cessation of life, Chronic Kidney Diseases, Diabetes, Failure (biologic function), Kidney, Mortality Vital Statistics, Nordisk, Obesity, semaglutide, Wegovy

** Ozempic, Novo Nordisk, diabetes, chronic kidney disease, mortality risk, cardiovascular deaths, kidney failure, semaglutide, Wegovy, obesity treatment

Eli Lilly Invests $5.3 Billion to Boost Production of Mounjaro and Zepbound

11 months ago11 months ago talkbio0Tagged Diabetes, Drug Industry, eli lilly, Investments, Manufacture, Mounjaro, Obesity, Weight Loss, Zepbound

** Eli Lilly, Mounjaro, Zepbound, Manufacturing, Investment, Diabetes, Obesity, Weight Loss, Pharmaceutical Industry